Abstract Background Tumor recurrence and mortality rates remain challenging in cancer patients despite comprehensive treatment. Neoadjuvant chemotherapy and immunotherapy aim to eliminate residual tumor cells. reducing the risk of recurrence. However. https://www.roomyroomers.shop/product-category/shelf/